| Titles listed in order of publication— | |
 |
January/February 2001 |
| Page | Title |
| 2 | Stability of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide in Fresh Blood and Plasma and Postmortem Blood Samples |
| 8 | A Mass Spectrometric Method for Quantitation of Intact Insulin in Blood Samples |
| 15 | The Relative Buffering Capacities of Saliva and Moist Snuff: Implications for Nicotine Absorption |
| 26 | FT-IR Breath Test in the Diagnosis and Control of Treatment of Methanol Intoxications |
| 31 | Detection and Quantitation of Morphine in Fixed Tissues and Formalin Solutions |
| 35 | Simultaneous Determination of 2,4-D and MCPA in Canine Plasma and Urine by HPLC with Fluorescence Detetion Using 9-Anthryldiazomethane (ADAM) |
| 40 | Analysis of Methadone and its Metabolites in Meconium by Enzyme Innumoassay (EMIT®) and GC–MS |
| 45 | Computer-Aided Screening for Hallucinogenic and Stimulant Amphetamines with Gas Chromatography–Fourier Transform Infrared Spectroscopy (GC–FTIR) |
| 57 | Bioanalysis of the Enantionmers of (±)-Sarin using Automated Thermal Cold-Trap Injection Combined with Two-Dimensional Gas Chromatography |
| 62 | Immunoassay for Detection of Cocaine/Metabolites in Oral Fluids |
| 69 | Rapid Confirmation/Quantitation of Ecgonine Methyl Ester, Benzoylecgonine, and Cocaine in Urine Using On-Line Extraction Coupled with Fast HPLC and Tandem Mass Spectrometry |
|
March 2001 |
| Page | Title |
| 77 | Cobas Mira™ S Endpoint Enzymatic Assay for Plasma Formate |
| 81 | Quantitation of Morphine and Codeine in Human Urine using High-Field Asymmetric Waveform Ion Mobility Spectrometry (FAIMS) with Mass Spectrometric Detection |
| 88 | In Vitro Reaction of Formaldehyde with Fenfluramine: Conversion to N-Methyl Fenfluramine |
| 93 | GC–MS Determination of Heroin Metabolites in Meconium: Evaluation of Four Solid-Phase Extraction Cartridges |
| 99 | Analysis of Amphetamine and Congeners in Illicit Samples by Liquid Chromatography and Capillary Electrophoresis |
| 106 | Acetylcodeine as a Marker for Illicit Heroin in Human Hair: Method Validation and Results of a Pilot Study |
| 112 | The Effect of Swallowing or Rinsing Alcohol Solution on the Mouth Alcohol Effect and Slope Detection of the Intoxilyzer 5000 |
| 115 | Screening Method for Seventy Psychoactive Drugs or Drug Metabolites in Serum based on High-Performance Liquid Chromatography–Electrospray Ionization Mass Spectrometry |
| 125 | General Unknown Screening in Postmortem Tissue and Blood Samples: A Semi-Automatic Solid-Phase Extraction using Polystyrene Resins Followed by Liquid–Liquid Extraction |
| 130 | Analytical Methodology for the Detection of Benzodiazepine Consumption in Opioid-Dependent Subjects |
| 137 | Improved Solid-Phase Extraction Method for Systematic Toxicological Analysis in Biological Fluids |
| 144 | TECHNICAL NOTE: Sweat Testing of MDMA with the Drugwipe® Analytical Device: A Controlled Study with Two Volunteers |
| 147 | CASE REPORT: A Fatal Case of Serotonin Syndrome after Combined Moclobemide–Citalopram Intoxication |
| 152 | LETTER TO THE EDITOR: The Presence of Gamma-Hydroxybutyric Acid (GHB) in Postmortem Biological Fluids |
|
April 2001 |
| Page | Title |
| 153 | Routine Gas Chromatographic Determination of Dialkylphosophate Metabolites in the Urine of Workers Occupationally Exposed to Organophosphorus Insecticides |
| 158 | Amphetamine, Clobenzorex, and 4-Hydroxyclobenzorex Levels Following Mulitdose Administration of Clobenzorex |
| 166 | Stability of Benzodiazepines in Formaldehyde Solutions |
| 174 | Positive Predictive Values of Abused Drug Immunoassays on the Beckman Synchron in a Veteran Population |
| 179 | Isotopic Analogues as Internal Standards for Quantitative Analyses of Drugs and Metabolites by GC–MS—Nonlinear Calibration Approaches |
| 190 | Evaluation of Immunoassays for Semiquantitative Detection of Cocaine and Metabolites or Heroin and Metabolites in Extracts of Sweat Patches |
| 198 | Analysis of Paracetamol Using Solid-Phase Extraction, Deuterated Internal Standards, and Gas Chromatography–Mass Spectrometry |
| 203 | Qualitative Screening for Drugs of Abuse in Hair using GC–MS |
| 209 | Semiautomated High-Performance Liquid Chromatographic Method for the Determination of Benzodiazepines in Whole Blood |
| 215 | TECHNICAL NOTE: Concentration Verification of Ethanol/Nitrogen Compressed Gas Cylinders Prior to Use for Periodic Determinations of Accuracy in California |
| 219 | LETTER TO THE EDITOR: Ecgonine in an Important Marker for Cocaine Use in Inadequately Preserved Specimen |
|
May/June 2001 |
| Page | Title |
| 221 | Amphetamine and N-Acetylamphetamine Incorporation into Hair: An Investigation of the Potential Role of Drug Basicity in Hair Color Bias |
| 228 | Rapid Determination of Cyanide and Azide in Beverages by Microdiffusion Spectrophotometric Method |
| 237 | Screening Procedure for Detection of Non-Steroidal Anti-Inflammatory Drugs and their Metabolites in Urine as Part of a Systematic Toxicological Analysis Procedure for Acidic Drugs and Poisons by Gas Chromatography–Mass Spectrometry after Extractive Methylation |
| 245 | Severe Intoxication with the Veterinary Tranquilizer Xylazine in Humans |
| 250 | HPLC with Simultaneous UV and Reductive Electrochemical Detection at the Hanging Mercury Drop Electrode: A Highly Sensitive and Selective Tool for the Determination of Benzodiazepines in Forensic Samples |
| 258 | Profiles of Urine Samples Taken from Ecstacy Users at Rave Parties: Analysis by Immunoassays, HPLC, and GC–MS |
| 270 | 1H NMR Spectroscopic Investigation of Serum and Urine in a Case of Acute Tetrahydrofuran Poisoning |
| 275 | Simultaneous Determination of Chlorpyrifos, Permethrin, and Their Metabolites in Rat Plasma and Urine by High-Performance Liquid Chromatography |
| 280 | Clenbuterol in the Horse: Confirmation and Quantitation of Serum Clenbuterol by LC–MS–MS after Oral and Intratracheal Administration |
|
July/August 2001 |
| Page | Title |
| 289 | Detection of Marijuana Use by Oral Fluid and Urine Analysis Following Single-Dose Administration of Smoked and Oral Marijuana |
| 304 | Analysis of Pyrolysis Products of Dimethylamphetamine |
| 310 | Laboratory Analysis of Remotely Collected Oral Fluid Specimens for Opiates by Immunoassay |
| 316 | Investigation Into Some Aspects of EMIT d.a.u., TLC, and GC–MS Urinalysis of Bromazepam |
| 323 | Comparison of HPLC and GC–MS Methods for Determination of Embutramide (A Component of Tanax® or T-61®) in Biological Specimens |
| 328 | Improved Procedure for the Analysis of Gamma-Hydroxybutyrate and Ethylene Glycol in Whole Blood |
| 333 | TECHNICAL NOTE: The Antispasmodic Drug Mebeverine Leads To Positive Amphetamine Results by Fluorescence Polarization Immunoassay (FPIA)—Studies on the Toxicological Analysis in Urine by FPIA and GC–MS |
| 339 | TECHNICAL NOTE: Importance of Vacutainer Selection in Forensic Toxicological Analysis of Drugs of Abuse |
| 344 | CASE REPORT: Dermal Exposure to Strychnine |
| 348 | CASE REPORT:Concentrations of cis(Z)-Clopenthixol and trans(E)-Clopenthixol in a Lethal Case Involving Zuclopenthixol, Diazepam, and Cyamemazine |
| 353 | LETTER TO THE EDITOR: Heroin Use by Motorists in Sweden Confirmed by Analysis of 6-Acetylmorphine in Urine |
| 356 | LETTER TO THE EDITOR: Response to The Presence of Gamma-Hydroxybutyric Acid (GHB) in Postmortem Biological Fluids |
| 358 | 2000 SOFT Meeting Abstracts and Plenary Papers |
| 359 | SOFT Meeting Abstracts |
|
September 2001 |
| Page | Title |
| 386 | Informatics and Scientific Information Exchange |
| 390 | Ethics for Toxicologists: An Examination of Conscience |
| 393 | Alternate Strategies for Postmortem Drug Testing |
| 396 | Alternative Specimens for Workplace Drug Testing |
| 400 | Amphetamines: An Update on Forensic Issues |
| 405 | Genetic Mechanisms for Variability in Drug Response and Toxicity |
| 414 | Structural MRI as a Tool for the Study of Neurotoxicity and Neurodegenerative Disorders |
| 419 | fMRI: A New Tool for the In Vivo Localization of Drug Actions in the Brain |
| 425 | Analysis of Cocaine, Benzoylecgonine, Ecgonine Methyl Ester, and Ecgonine by High-Pressure Liquid Chromatography–API Mass Spectrometry and Application to a Short-Term Degradation Study of Cocaine in Plasma |
| 431 | Detection of Non-Prescription Heroin Markers in Urine with Liquid Chromatography–Atmospheric Pressure Chemical Ionization Mass Spectrometry |
| 439 | Protein Binding of Glufosinate and Factors Affecting it Revealed by an Equilibrium Dialysis Technique |
| 443 | In Vitro Reaction of Barbiturates with Formaldehyde |
| 450 | Assessing Chronic Exposure to Fumonisin Mycotoxins: The Use of Hair as a Suitable Noninvasive Matrix |
| 456 | A Detection Scheme for Paraquat Poisoning: Validation and a Five-Year Experience in Australia |
| 461 | Blood Lead and Zinc in Pregnant Women and their Offspring in Intrauterine Growth Retardation Cases |
| 466 | TECHNICAL NOTE: Effects of Stealth™ Adulterant on Immunoassay Testing for Drugs of Abuse |
| 471 | TECHNICAL NOTE: Evaluation of Roche Abuscreen ONLINE Amphetamine Immunoassay for Screening of New Amphetamine Analogues |
| 476 | TECHNICAL NOTE: Identification and Quantitation of 11-Nor-Ð9-Tetrahydrocannabivarin-9-Carboxylic Acid, a Major Metabolite of Ð9-Tetrahydrocannabivarin |
| 481 | CASE REPORT: LC–EI-MS Determination of Veratridine and Cevadine in Two Fatal Cases of Veratrum album Poisoning |
| 486 | LETTER TO THE EDITOR: Concentration Ratios of Codeine-to-Morphine in Plasma after a Single Oral Dose (100 mg) of Codeine Phosphate |
|
October 2001 |
| Page | Title |
| 490 | Effect of Four Laboratory Decontamination Procedures on the Quantitative Determination of Cocaine and Metabolites in Hair by HPLC–MS |
| 497 | A Validated Liquid Chromatography–Atmospheric Pressure Chemical Ionization-Tandem Mass Spectrometry Method for Quantitation of Cocaine and Benzoylecgonine in Human Plasma |
| 504 | Urinary Excretion Profiles for Total Morphine, Free Morphine, and 6-Acetylmorphine Following Smoked and Intravenous Heroin |
| 515 | Detection of Opiate Use in a Methadone Maintenance Treatment Population with the CEDIA® 6-Acetylmorphine and CEDIA DAU Opiate Assays |
| 520 | Gas Chromatography–Mass Spectrometry Confirmation of Cozart RapiScan Saliva Methadone and Opiate Tests |
| 525 | Cathinone (Khat) and Methcathinone (CAT) in Urine Specimens: A Gas Chromatographic–Mass Spectrometric Detection Procedure |
| 531 | Simultaneous Determination of D9-Tetrahydrocannabinol and 11-nor-9-Carboxy-D9-Tetrahydrocannabinol in Human Plasma by Solid-Phase Extraction and Gas Chromatography–Negative Ion Chemical Ionization-Mass Spectrometry |
| 538 | Temporal Indication of Marijuana Use Can Be Estimated from Plasma and Urine Concentrations of D9-Tetrahydrocannabinol, 11-Hydroxy-D9-Tetrahydrocannabinol, and 11-nor-D9-Tetrahydrocannabinol-9-Carboxylic Acid |
| 550 | Solid-Phase Extraction and GC–MS Analysis of THC-COOH Method Optimized for a High-Throughput Forensic Drug-Testing Laboratory |
| 555 | The Determination of 11-nor-D9-Tetrahydrocannabinol-9-Carboxylic Acid (THC-COOH) in Hair using Negative Ion Gas Chromatography–Mass Spectrometry and High-Volume Injection |
| 559 | A Comparison of Roche Kinetic Interaction of Microparicles in Solution (KIMS®) Assay for Cannabinoids and GC–MS Analysis for 11-nor-9-Carboxy-Ð9-Tetrahydrocannabinol |
| 565 | D9-Tetrahydrocannabivarin as a Marker for the Ingestion of Marijuana versus Marinol®: Result of a Clinical Study |
| 572 | Analysis of Morphine and Codeine in Samples Adulterated with Stealth™ |
| 576 | Application of a Convenient Extraction Procedure for the Analysis of Gamma-Hydroxybutyric Acid in Fatalitites Involving Gamma-Hydroxybutyric Acid |
| 583 | Urine Concentrations of Ketamine and Norketamine Following Illegal Consumption |
| 589 | Hydrolysis of Conjugated Metabolites of Buprenorphine. I. The Quantitative Enzymatic Hydrolysis of Buprenorphine-3-b-D-Glucuronide in Human Urine |
| 594 | Incorporation of Seleciline Metabolites into Hair after Oral Selegiline Intake |
| 602 | Development of a Generic Method to the Solid-Phase Extraction of Acidic Compounds from Complex Matrices |
| 607 | 3H-Nicotine, 3H-Flunitrazepam, and 3H-Cocaine Incorporation Into Melanin: A Model for the Examination of Drug–Melanin Interactions |
| 612 | Evaluation of an Onsite Testing Device for Use in Postmortem Forensic Toxicology |
| 616 | Extraction of Benzoylecgonine from Urine Specimens with Cerex Polycrom™ Clin II Solid-Phase Extraction Columns and the Speedisk™ Pressure Processor |
| 621 | TECHNICAL NOTE: Rapid Detection of Benzoylecgonine in Vitreous Humor by Enzyme Innumoassay |
| 625 | TECHNICAL NOTE: The Detection of Drugs of Abuse in Liquid Perspiration |
| 628 | TECHNICAL NOTE: Ether: Stability in Preserved blood Samples and a Case of Ether-Assisted Suicide |
| 631 | TECHNICAL NOTE: A Comprehensive Screen for Volatile Organic Compounds in Biological Fluids |
| 637 | TECHNICAL NOTE: Urine Analysis of Laboratory Personnel Preparing Cocaine Training Aids for a Military Working Dog Program |
| 641 | CASE REPORT: Cialopram Distribution in Postmortem Cases |
| 645 | CASE REPORT: Fatalities Caused by the MDMA-Related Drug, Paramethoxyamphetamine |
| 649 | CASE REPORT: Three Cases of Fatal Paramethoxyamphetamine Overdose |
| 652 | CASE REPORT: A Contemporaneous Finding of Fenproporex in a Polydrug Suicide |
| 657 | LETTER TO THE EDITOR: Application of Opiate Cutoffs to Opiate Intoxication Cases |
|
November/December 2001 |
| Page | Title |
| 659 | Mechanistic Studies on the Use of 2H- and 13C-Analogues as Internal Standards in Selected Ion Monitoring GC–MS Quantitative Determination—Butalbital Example |
| 670 | Performance of Five Non-Instrumented Urine Drug-Testing Devices with Challenging Near-Cutoff Specimens |
| 680 | Determination of Glufosinate Ammonium and its Metabolite, 3-Methylphosphinicopropionic Acid, in Human Serum by Gas Chromatography–Mass Spectrometry following Mixed-Mode Solid-Phase Extraction and t-BDMS Derivatization |
| 685 | Human Nutritional Supplements in the Horse. Dehydroepiandrosterone versus Androstenedione: Comparative Effects on the Androgen Profile and Consequences for Doping Analysis |
| 691 | Evaluating the Impact of Hemp Food Consumption on Workplace Drug Tests |
| 699 | Serum and Urine Concentrations of Flunitrazepam and Metabolites, after a Single Oral Dose, by Immunoassay and GC–MS |
| 705 | TECHNICAL NOTE: Fatal 4-MTA Intoxication: Development of a Liquid Chromatographic–Tandem Mass Spectrometric Assay for Multiple Matrices |
| 711 | TECHNICAL NOTE: Analysis of the Lidocaine Metabolite 2,6-Dimethylaniline in Bovine and Human Milk |
| 716 | LETTER TO THE EDITOR: A Fatal Case of Moclobemide– Citalopram Intoxication |
| Home | Subscribe | Current Issue | Back Issues | Search | Advertise | Other Publications |